Dismembered Pyeloplasty With and Without After Coming Stent
1 other identifier
interventional
30
1 country
1
Brief Summary
to compare outcome of pyeloplasty in pediatric population less than 6 months in age using an after coming stent versus stentless pyeloplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 10, 2014
CompletedFirst Posted
Study publicly available on registry
May 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJanuary 20, 2016
January 1, 2016
1.2 years
May 10, 2014
January 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postoperative Hospital stay
Postoperative Hospital stay
1 week
Leakage
occurrence of post operative leakage
1 week
2ry intervention
Need for 2ry intervention in the form of insertion of ureteral stent
1 month
Fever
Postoperative fever
1 month
Secondary Outcomes (2)
Assessment of kidney function after repair
6 months
success
6 months
Study Arms (2)
After coming stent
ACTIVE COMPARATORDismembered pyeloplasty with insertion of an after coming stent
Stentless
ACTIVE COMPARATORStentless dismembered pyeloplasty
Interventions
Dismembered pyeloplasty through lumbar incision. The patients who are randomized to the after coming stent arm, an after coming stent is inserted. Distal part of it is positioned in the mid ureter. The proximal end is passed through the renal parenchyma (usually the lower kidney calyx) to be exteriorized through stab wound and fixed to the skin. The size of external stent is 4-5 F.
Dismembered pyeloplasty through lumbar incision. No stents are inserted
Eligibility Criteria
You may qualify if:
- Pelvi-ureteric junction obstruction (PUJO)
- Asymptomatic obstruction with reduced function (less than 35-40%)
- Asymptomatic obstruction with antero-posterior diameter exceed 40 mm
- Asymptomatic obstruction with deterioration on conservative follow up.
- Symptomatic PUJ obstruction, e.g. pain, renal mass, fever and stones.
You may not qualify if:
- Secondary Pelvi-ureteric junction obstruction
- Solitary kidney
- Gross pyuria
- Ectopic kidney
- Dilated ureter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University Hospitals
Cairo, 12222, Egypt
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammed S ElSheemy, A professor
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associte professor of urology
Study Record Dates
First Submitted
May 10, 2014
First Posted
May 15, 2014
Study Start
January 1, 2014
Primary Completion
March 1, 2015
Study Completion
June 1, 2015
Last Updated
January 20, 2016
Record last verified: 2016-01